Tiziana Life Sciences PLC (TILS) Rating Reiterated by Beaufort Securities

Tiziana Life Sciences PLC (LON:TILS)‘s stock had its “speculative buy” rating restated by research analysts at Beaufort Securities in a research report issued to clients and investors on Friday. They currently have a GBX 400 ($5.06) price objective on the biotechnology company’s stock. Beaufort Securities’ target price would indicate a potential upside of 132.05% from the company’s previous close.

Tiziana Life Sciences PLC (LON TILS) opened at 168.00 on Friday. The stock’s market cap is GBX 158.58 million. The stock has a 50 day moving average of GBX 204.28 and a 200 day moving average of GBX 197.21. Tiziana Life Sciences PLC has a 1-year low of GBX 102.06 and a 1-year high of GBX 240.00.

TRADEMARK VIOLATION WARNING: This piece of content was first reported by Mideast Time and is the property of of Mideast Time. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of United States and international copyright legislation. The legal version of this piece of content can be read at https://www.mideasttime.com/tiziana-life-sciences-plc-tils-rating-reiterated-by-beaufort-securities/1775276.html.

Tiziana Life Sciences PLC Company Profile

Tiziana Life Sciences PLC is a clinical-stage biotechnology company. The Company is focused on targeted drugs to treat diseases in oncology and immunology, with a focus on metastatic cancers. Its products in clinical stage include Milciclib and Foralumab. Its products in pre-clinical stage include TZLS-101 and TZLS-214.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “LSE:TILS”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Receive News & Ratings for Tiziana Life Sciences PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tiziana Life Sciences PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

© 2006-2017 Mideast Time.